| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 27, 2013 | Alpha Street Research | Hunter Orr | THLD - Threshold Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report | 9 | $24 | | May 24, 2013 | S&P Capital IQ Quantitative Report | N/A | Threshold Pharmaceuticals | 3 | $34.50 | | May 24, 2013 | Pechala's Reports | Frantisek Pechala | THRESHOLD PHARMACEUTICALS INC (THLD) 12-months forecast | 1 | $15 | | May 23, 2013 | New Constructs, LLC | N/A | THLD: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: THRESHOLD PHARMA -- THLD | 1 | $11.50 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: CXM , RNN , THLD -- DRUGS | 3 | $34.50 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for THLD | 11 | $126.50 | | May 15, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Threshold Pharmaceuticals, Inc. | 40 | $460 | | May 14, 2013 | Zacks Investment Research Inc. | N/A | THRESHOLD PHARM (THLD) Zacks Company Snapshot | 1 | $11.50 | | May 13, 2013 | Zacks Investment Research Inc. | N/A | THRESHOLD PHARM (THLD) Zacks Company Snapshot | 1 | $11.50 |
|
View All Reports for THLD ... |
|
|
0.09(1.60%) May 24, 4:00PM EDT|After Hours
:
5.54